Casey Butrus, PharmD: I know there have been some new therapies, but I wouldn’t say necessarily a lot, that have been FDA approved within the past 4 to 5 years for acne. Steve, I was wondering if you ...

Acne vulgaris on the back of a healthy 13-year-old boy A dermatologist explores dealing with increasing bacterial resistance and selecting the treatment that minimizes irritation and other skin ...

From newborn to older adult, acne can break out at any age. And while it's most common in adolescence and early adulthood, ...

Acne vulgaris is a multifactorial skin disorder marked by inflammatory and non-inflammatory lesions that can cause significant physical and psychological distress. Traditional treatment options, ...

Please provide your email address to receive an email when new articles are posted on . Antibiotics were frequently used for longer than the 3- to 4-month duration recommended for acne treatment.

Patient-reported outcome (PRO) measures were included in approximately one-half of acne vulgaris and rosacea randomized controlled trials, despite their utility in capturing the patient perspective.

Please provide your email address to receive an email when new articles are posted on . 10.5% of patients treated with isotretinoin experienced mood changes. 88% of patients experienced symptom ...

The approval of Winlevi was based on data from 2 double-blind, vehicle-controlled phase 3 trials in 1440 patients with facial acne vulgaris. Winlevi ® (clascoterone cream 1%) is now available for the ...

Advance Market Analytics published a new research publication on “Global Acne Vulgaris Drug Market Insights, to 2027” with 232 pages and enriched with self-explained Tables and charts in presentable ...

These perceptions may not readily include bacterial resistance. However, antimicrobial treatment of acne vulgaris is usually a long-term process. There is a strong possibility that resistant strains ...